Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Sun Pharmaceutical Industries, Inc., under the existing ANDA.
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for cetirizine hydrochloride by Padagis Israel Pharmaceuticals Ltd. The document indicates the actio…
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects [Phase 3]
This update reports the Phase 3 results of olopatadine hydrochloride ophthalmic solution tested in Chinese subjects for allergic conjunctivi…
-
FDA approval · 2016-08-26FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Visine Allergy Eye Relief Multi-Action, a combination of naphazoline hydrochloride and pheni…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
A completed clinical trial evaluated patients with allergic conjunctivitis to determine whether they also have dry eye disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis [Phase 3]
Phase III trial evaluating the safety and efficacy of a 300 IR grass pollen sublingual immunotherapy (SLIT) for grass pollen rhinoconjunctiv…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis [Phase 2]
Phase 2 trial assessing different concentrations of SPARC1102 for allergic conjunctivitis has completed with results posted in 2016.
-
FDA approval · 2016-05-12FDA Approved: CARBINOXAMINE MALEATE EXTENDED-RELEASE ORAL SUSPENSION — Supplemental Application (Neos Therapeutics, LP)
FDA approved a supplemental application to authorize a new extended-release oral suspension formulation of carbinoxamine maleate by Neos The…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis [Phase 2]
Phase 2 study of OTX-DP for chronic allergic conjunctivitis completed with posted results.
-
FDA approval · 2016-03-14FDA Approved: EYE ALLERGY RELIEF — Supplemental Application (DOLGENCORP, LLC)
FDA approved a supplemental application for Eye Allergy Relief (pheniramine maleate and naphazoline hydrochloride) from DolgenCorp, LLC unde…
-
FDA approval · 2016-03-10FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Visine Allergy Eye Relief Multi-Action, a combination product containing naphazoline hydrochlori…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial update for AGN-229666 ophthalmic solution in Japanese patients with allergic conjunctivitis has completed with result…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis [Phase 3]
A Phase 3 clinical trial update for a multi-center environmental treatment of moderate to severe ocular allergic conjunctivitis has complete…
-
FDA approval · 2016-02-05FDA Approved: BEPOTASTINE BESILATE — Supplemental Application (Bausch & Lomb Americas Inc.)
The FDA approved a supplemental application for bepotastine besilate (an antihistamine eye drop) submitted by Bausch & Lomb Americas Inc.
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
Completed clinical trial comparing patient-reported ocular comfort between Bepreve and Lastacaft in allergic conjunctivitis.
-
FDA approval · 2016-01-13FDA Approved: ALOCRIL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for ALOCRIL (nedocromil sodium) by Allergan, Inc. The action approves changes described in the suppl…
-
FDA approval · 2015-12-18FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Harris Teeter)
FDA approved the original application for olopatadine hydrochloride (ophthalmic) from Harris Teeter, marking the approval of a generic produ…
-
FDA approval · 2015-12-07FDA Approved: OLOPATADINE — Original Application (Somerset Therapeutics, LLC)
FDA approved an original ANDA for olopatadine from Somerset Therapeutics, LLC, authorizing a generic ophthalmic product.
-
FDA approval · 2015-12-07FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s original application for olopatadine hydrochloride, a generic antihistamine eye drop for allergic conjunctiv…
-
FDA approval · 2015-12-07FDA Approved: OLOPATADINE HCL — Original Application (Sola Pharmaceuticals)
FDA approved the generic olopatadine HCl ophthalmic solution from Sola Pharmaceuticals through an Original Application. This approval provid…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy [Phase 2]
A Phase 2 randomized trial evaluating a novel method of specific allergen immunotherapy for grass pollen-induced rhinoconjunctivitis has com…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
A pilot clinical trial evaluated a cutaneous antigen neutralization test in patients with rhinoconjunctivitis; the study has completed.
-
FDA label_change · 2015-11-27FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for Pataday Once Daily Relief (olopatadine hydrochloride) from Alcon Laboratories, Inc. to update th…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts [Phase 3]
A Phase 3 multicenter clinical trial is evaluating the safety and efficacy of specific immunotherapy using modified allergen extracts for al…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children [Phase 3]
A multicenter Phase 3 trial evaluating sublingual grass pollen allergen extract for children with allergic rhinoconjunctivitis has completed…